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examine the inﬂuence of access site on outcomes.Background Little is known about the outcomes of PCI in EO patients.Methods We analyzed CathPCI Registry data from patients who underwent radial or femoral PCI and were discharged between
July 2009and June 2011 and compared in-hospital outcomes of EO (N¼83,861)with those of NWpatients (BMI 20 to
25 kg/m2; N ¼ 217,616). Outcomes included in-hospital mortality and procedural and bleeding complications.
Multivariable logistic regression models were used to assess the independent association of EO with outcomes, using
previously validated risk models derived from the CathPCI Registry. The role of access site was speciﬁcally examined.Results Compared with NW patients, EO patients were younger (median age 60 vs. 69 years), more likely female (47% vs.
37%), and more likely African American (12% vs. 7%). EO patients had lower unadjusted mortality (1.2% vs. 2.0%);
however, after multivariable adjustment, EO was independently associated with increased risk of in-hospital
mortality (odds ratio: 1.22; 95% CI: 1.08 to 1.39) in those presenting with ST-segment elevation myocardial
infarction (STEMI). Access site had no effect on bleeding or outcome.Conclusions EO patients who underwent PCI were younger and had less bleeding compared with NW patients. After multivariable
adjustment for risk,EOwas independentlyassociatedwithhigher in-hospitalmortalityoverall andparticularly in thepatients
undergoing STEMI. (J Am Coll Cardiol 2013;62:692–6)ª 2013 by the American College of Cardiology FoundationFrom 1986 to 2000, the prevalence of extreme obesity (EO),
deﬁned as body mass index (BMI) 40 kg/m2, quadrupled
in the United States, and currently 1 in 50 adult Americans
is extremely obese (1). EO has been linked with operative
and late mortality after coronary artery bypass grafting
(CABG) (2), yet little is known about the outcomes of
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, 2012; revised manuscript received May 17,BMI 45 kg/m2 was an independent risk factor for 30-day
mortality in patients undergoing CABG (3).
Conversely, studies have indicated better PCI outcomes in
obese patients compared with normal-weight (NW) patients
(4), the so-called “obesity paradox,”with better outcomes being
attributed to more intensive medical therapy (5), early referral
(6), and reduced bleeding and other vascular complications due
to the use of radial access and vascular closure devices (7).
We hypothesized that EO patients undergoing PCI have
higher post-procedure in-hospital morbidity and mortality
and used the CathPCI Registry to test this hypothesis.
Methods
This studywas a retrospective analysis of in-hospital outcomes
of PCI among EO patients compared with those of NW
patients included in the CathPCI Registry. This registry
is a national reporting system designed for quality improve-
ment of diagnostic cardiac catheterization and PCI proce-
dures, sponsored jointly by the American College of
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693Cardiology (ACC) and the Society for Cardiovascular
Angiography and Interventions (SCAI) (8,9). Pre-deﬁned
data are collected that include only in-hospital events (10),
with neither angiographic nor in-hospital outcomes being
adjudicated.
This study included patients 18 years of age who had
undergone PCI via the femoral or radial artery; were
discharged between July 1, 2009, and June 30, 2011; and
had BMI 40 kg/m2 (EO group) or BMI between 20 and
25 kg/m2 (NW group). Risk factors, comorbid conditions,
and hospital characteristics of interest are listed in Table 1.
Pre-procedural and procedural characteristics of interest
are listed in Table 2. Outcomes of interest included in-
hospital death, bleeding, and intraprocedure and post-
procedure adverse events. Bleeding was deﬁned as the
presence of one or more of the following: <72 h of PCI; any
access site, retroperitoneal, intracranial, gastrointestinal, or
genitourinary bleeding; cardiac tamponade; or non-bypass
surgery–related blood transfusion in patients with a pre-
PCI hemoglobin (Hgb) 8 g/dl or an absolute decrease
from pre-PCI Hgb 3 g/dl in patients with a pre-PCI
Hgb 16 g/dl. Intraprocedure and post-procedure events
of interest are listed in Table 3.
Baseline characteristics were compared between NW and
EO patients using the Wilcoxon rank-sum test for contin-
uous variables, presented as median (25th, 75th interquartile
range), and the chi-square test for categorical variables,
presented as counts (proportions). Adjusted associations
between EO and outcomes were examined using logistic
regression and presented as odds ratios (ORs). Adjustment
models for each outcome were based on previously devel-
oped CathPCI Registry models for bleeding (11) and
mortality, with initial models including 28 covariates
for bleeding and 25 for mortality and the ﬁnal model
including 7 covariates as listed in the footnote of Figure 1.
Additional stratiﬁed analysis was performed by presentation
(ST-segment elevation myocardial infarction [STEMI] and
non-STEMI). To assess the inﬂuence of femoral versus
radial access on the relationship between outcomes and
EO, a test of interaction between arterial access and EO
in the regression models of bleeding was performed. A
p value <0.05 was considered signiﬁcant. All analyses were
performed using SAS version 9.2 (SAS Institute, Cary,
North Carolina).
Results
Of a total of 1,221,086 admissions included in the registry,
83,861 were EO patients and 217,616 were NW; these
2 groups were included in this study. As compared with NW
patients, EO patients had lower median age, higher female-
to-male ratio, higher proportion of African Americans, and
markedly higher prevalence of diabetes mellitus, hyperten-
sion, and hyperlipidemia. A history of PCI was more
common in this group, but cerebrovascular and peripheral
vascular diseases were more common in the NW patients.The distribution of clinical
characteristics in these groups is
presented in Table 1.
Emergency PCI was per-
formed in 13% of EO patients
versus 20% in NW patients,
STEMI in 12% versus 19%, and
cardiogenic shock <24 h present
in 2% versus 4%. EO patients had
less extensive coronary disease,
with less multivessel disease,
fewer lesions with Thrombolysis
In Myocardial Infarction ﬂow grade 0, and fewer high-risk
Society of Coronary Angiography and Interventions (SCAI)
class lesions (SCAI class >1). Transradial access was used
more often in these patients. Although PCI procedures were
mostly performed in urban hospitals, the distributions of
these 2 groups among hospital locations were not signiﬁcantly
different. Most procedures were performed in the South, yet
procedures for EO patients were more prevalent in the
Midwest. The distribution of procedural characteristics in
these groups is presented in Table 2.
Unadjusted, the EO group had a lower rate of mortality,
bleeding, periprocedural MI, cardiogenic shock, heart
failure, and tamponade and higher rates of renal failure and
access hematoma. The in-hospital outcomes of the EO
group and the NW group are shown in Table 3. After
multivariable adjustment, EO was independently associated
with a higher mortality rate (OR: 1.14; 95% CI: 1.04 to
1.25; p ¼ 0.005) and a lower bleeding rate (OR: 0.80; 95%
CI: 0.76 to 0.83; p < 0.001) (Fig. 1). In stratiﬁed analysis by
presentation in the STEMI and non-STEMI subgroups,
EO remained independently associated with higher
mortality in the STEMI subgroup, whereas the association
did not reach statistical signiﬁcance in the non-STEMI
subgroup (Table 4).
The interaction of femoral versus radial access with
outcomes was not statistically signiﬁcant (p ¼ 0.10
for bleeding and p ¼ 0.70 for mortality). In stratiﬁed
analysis and in both unadjusted and multivariable-adjusted
models, bleeding complication rates were lower for EO
patients compared with NW patients in both femoral and
radial subgroups. Among femoral patients, the unadjusted
OR of bleeding complications for EO versus NW was
0.69 (95% CI: 0.67 to 0.72; p < 0.001) and the
multivariable-adjusted OR was 0.79 (95% CI: 0.76 to
0.84; p < 0.001). Among radial cases, the unadjusted
OR of bleeding complications for EO versus NW was
0.64 (95% CI: 0.54 to 0.76; p < 0.001) and the
multivariable-adjusted OR was 0.76 (95% CI: 0.62 to
0.94; p ¼ 0.011).
Discussion
We compared the in-hospital outcomes of PCI in EO
patients with those of patients with normal BMI and found
Table 1
Baseline Characteristics of Study Patients in
Extremely Obese (BMI >40 kg/m2) and
Normal-Weight Groups (BMI 20 to 25 kg/m2)
Variable
Normal
Weight
Extremely
Obese p Value*
Age (yrs) 69 (59, 79) 60 (52, 67) <0.0001
Female:male (%) 37:63 47:53 <0.0001
Race <0.0001
African American 15,834 (7) 9,854 (12)
White 189,118 (87) 72,253 (86)
Other 10,524 (5) 1,055 (1)
Hypertension 165,301 (76) 75,775 (90) <0.0001
Dyslipidemia 162,160 (75) 69,753 (83) <0.0001
Diabetes mellitus <0.0001
All 50,660 (33) 51,358 (61)
Noninsulin 34,633 (16) 27,042 (32)
Insulin 16,027 (7) 24,334 (29)
Cerebrovascular disease 30,828 (14) 8,986 (11) <0.0001
Peripheral vascular disease 32,321 (15) 8,744 (10) <0.0001
Chronic lung disease 36,974 (17) 16,190 (19) <0.0001
Previous coronary intervention 81,272 (37) 34,559 (41) <0.0001
Currently on dialysis 6,625 (3) 2,088 (2) <0.0001
Renal failure
(GFR <30 ml/min/1.73 m2
or dialysis)
10,813 (5) 4,124 (5) 0.561
Chronic kidney disease <0.0001
GFR 45–591ml/min/1.73 m2 33,240 (15) 12,897 (15)
GFR 30–44 ml/min/1.73 m2 14,870 (7) 6,632 (8)
GFR <30 ml/min/1.73 m2 20,099 (9) 8,120 (10)
Dialysis 6,625 (3) 2,088 (2)
Hospital location <0.0001
Rural 23,324 (11) 10,200 (12)
Suburban 66,310 (30) 24,516 (29)
Urban 127,982 (59) 49,145 (57)
Hospital type <0.0001
Government 3,003 (1) 1,198 (1)
Private/community 189,236 (87) 73,578 (88)
University 25,377 (12) 9,085 (11)
Hospital region <0.0001
West 38,708 (18) 10,179 (12)
Northeast 31,234 (14) 11,479 (14)
Midwest 57,013 (26) 28,002 (33)
South 90,636 (45) 34,195 (41)
Annual coronary
intervention volume
709 (436,
1,160)
727 (444,
1,167)
<0.0001
Values are median (25th, 75th interquartile range) or n (%). *p values are based on Pearson chi-
square tests for categorical variables and Wilcoxon rank-sum test for continuous variables.
BMI ¼ body mass index; GFR ¼ glomerular ﬁltration rate.
Table 2
Procedural Characteristics of Study Patients in
Extremely Obese (BMI >40 kg/m2) and
Normal-Weight Groups (BMI 20 to 25 kg/m2)
Variable Normal Weight Extremely Obese p Value*
STEMI presentation 41,092 (19) 10,109 (12) <0.0001
Lytics prior to PCI 2,779 (1) 797 (1) <0.0001
Cardiogenic shock <24 h 7,708 (4) 1,736 (2) <0.0001
PCI status <0.0001
Elective 90,857 (42) 39,164 (47)
Urgent 82,688 (38) 33,456 (40)
Emergency 43,105 (20) 10,963 (13)
Prior cardiogenic shock <24 h 5,631 (3) 1,207 (1) <0.0001
HF <2 weeks <0.0001
None 193,747 (89) 73,501 (88)
HF NYHA class <IV 17,490 (8) 7,943 (9)
HF NYHA class IV 6,379 (3) 2,417 (3)
Cardiac arrest <24 h 4,884 (2) 1,271 (2) <0.0001
No. of diseased vessels:
2 or 3 vs. 0 or 1
89,657 (41) 30,505 (36) <0.0001
Arterial access site <0.0001
Femoral 20,6363 (95) 75,601 (90)
Radial 11,165 (5) 8,232 (10)
Ejection fraction 55 (45, 60) 55 (48, 60) <0.0001
Missing, % 31 28
Highest-risk lesion <0.0001
SCAI class I 89,664 (41) 37,615 (45)
SCAI class II 87,858 (40) 33,466 (40)
SCAI class III 10,854 (5) 3,541 (4)
SCAI class IV 29,240 (13) 9,239 (11)
Highest-risk lesion
(SCAI class >I)
127,952 (59) 46,246 (55) <0.0001
Chronic total occlusion 6,090 (3) 2,475 (3) 0.023
Lesion segment <0.0001
Left main 5,252 (2) 1,444 (2)
pLAD 38,662 (18) 13,669 (16)
pRCA/mLAD/pCirc 82,047 (38) 30,794 (37)
Pre-procedure TIMI 0 39,464 (18) 12,556 (15) <0.0001
Values are median (25th, 75th interquartile range) or n (%). *p values are based on Pearson chi-
square tests for categorical variables and Wilcoxon rank-sum test for continuous variables.
HF ¼ heart failure; mLAD ¼ mid left anterior descending artery; NYHA ¼ New York Heart
Association; PCI ¼ percutaneous coronary intervention; pCirc ¼ proximal left circumﬂex artery;
pLAD ¼ proximal left anterior descending artery; pRCA ¼ proximal right coronary artery; SCAI ¼
Society of Cardiovascular Angiography and Intervention; STEMI ¼ ST-segment elevation myocardial
infarction; TIMI ¼ Thrombolysis In Myocardial Infarction; other abbreviation as in Table 1.
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hospital mortality in those presenting with STEMI.
However, in settings other than STEMI, EO was not
independently associated with increased in-hospital
mortality. EO patients selected for PCI were younger and
had less extensive coronary artery disease (CAD); PCI
procedures in this subgroup were performed in less emergent
settings with lesser procedural risk and were associated with
less bleeding.
With 83,861 EO patients included, this study has a large
sample size, making it possible to adjust for multiplecovariates, thus providing a unique opportunity to explain the
“obesity paradox” hypothesis described in prior studies (4–6).
This paradox pertains to the decreased rates of bleeding and
in-hospital mortality with increasing obesity and alludes to
a “protective effect” of obesity. In a recent study of patients
undergoing coronary angiography due to acute coronary
syndromes, medical therapy and PCI-treated patients who
were overweight (BMI 26.5 to 28 kg/m2) had the lowest risk
of mortality in unadjusted analysis; whenBMI as a continuous
variable was studied in patients with signiﬁcant CAD, the
adjusted risk for mortality decreased with increasing BMI up
to approximately 35 kg/m2 and then increased (12). Although
our ﬁndings from crude analysis were similar, after adjustment
for covariates, EO was independently associated with worse
outcomes in the STEMI presentation subgroup. Our ﬁndings
Table 3
Comparison of PCI In-Hospital Outcomes in
Extremely Obese Patients (BMI 40 kg/m2) and
Normal-Weight Patients (BMI 20 to 25 kg/m2)
In-Hospital Outcome Normal Weight Extremely Obese p Value*
In-hospital death 4,297 (1.97) 1,014 (1.21) <0.0001
Periprocedural MI 5,217 (2.40) 1,501 (1.79) <0.0001
Cardiogenic shock 3,186 (1.46) 638 (0.76) <0.0001
CHF 2,821 (1.30) 728 (0.87) <0.0001
CVA/stroke 625 (0.29) 168 (0.20) <0.0001
Hemorrhagic stroke 121 (0.06) 22 (0.03) 0.0009
Tamponade 280 (0.13) 48 (0.06) <0.0001
Renal failure 533 (0.24) 338 (0.40) <0.0001
Vascular
complications
1,142 (0.52) 429 (0.51) 0.6498
Bleeding 16,591 (7.62) 4,417 (5.27) <0.0001
Blood transfusion 8,027 (3.69) 2,265 (2.70) <0.0001
Bleeding within 72 h 4,944 (2.27) 1,571 (1.87) <0.0001
Access bleeding 1,320 (0.61) 481 (0.57) 0.2907
Access hematoma 1,882 (0.86) 818 (0.98) 0.0039
Retroperitoneal
bleeding
592 (0.27) 208 (0.25) 0.2501
Gastrointestinal
bleeding
926 (0.43) 193 (0.23) <0.0001
Genitourinary
bleeding
217 (0.10) 45 (0.05) 0.0001
Bleedingdother/
unknown
1,051 (0.48) 234 (0.28) <0.0001
Values are median n (%). *p values are based on Pearson chi-square tests for all categorical
variables.
CHF ¼ congestive heart failure; CVA ¼ cerebrovascular accident; other abbreviations as in
Tables 1 and 2.
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relationship between BMI and in-hospital outcomes of
patients with STEMI from the NCDR ACTION (Acute
Coronary Treatment and Intervention Outcomes Network)
Registry–GWTG (Get With the Guidelines) (13). In thatFigure 1
Unadjusted and Multivariate-Adjusted ORs of the Associati
Bleeding* and In-Hospital Mortalityy
*The multivariate model for bleeding complications included ST-segment elevation myoca
peripheral vascular disease (PVD), chronic lung disease (CLD), prior percutaneous corona
disease, cardiogenic shock and PCI status, heart failure New York Heart Association (NYH
Thrombolysis in Myocardial Infarction 0, number of diseased vessels (2 or 3 vs. 0 or 1), ly
in-stent thrombosis, Society of Coronary Angiography and Interventions class, highest-risk
status, hospital region, and average annual PCI volume. yThe mortality model included STE
cardiogenic shock and PCI status, heart failure NYHA class within 2 weeks, cardiac arrest
thrombosis, highest-risk lesion: segment category, number of diseased vessels (2 or 3 vs. 0
status, hospital region, and average annual PCI volume. The reference group is the patienstudy, 5.1% of the 50,149 STEMI patients were extremely
obese, were younger by a decade, had less extensive CAD, and
had better left ventricular systolic function. Similar to our
study and despite these advantages, EO was found to be
independently associated with higher in-hospital mortality.
Unmeasured factors such as pulmonary embolism and
difﬁculties with airway management may explain the
increased risk of in-hospital mortality associated with
STEMI in these patients. Moreover, it is plausible that
difﬁculties with obtaining venous or arterial access in EO
patients may be associated with increased complications;
however, there are few data to support it. In a registry
analysis, the transradial as compared with transfemoral
approach for PCI in EO patients was associated with less
major bleeding and less access site injuries (14); however, in
our study, the interaction of femoral versus radial access with
outcomes was not statistically signiﬁcant. This could be due
to the small number of radial procedures (9%) or relative
inexperience in transradial procedures.
In our study, EO was independently associated with less
in-hospital bleeding complications, which may reﬂect
underdosing of anticoagulants or higher use of closure devices
or transradial access. Although weight-based dosing protocols
for unfractionated heparin are not affected by morbid obesity,
data on weight-based dosing of low-molecular-weight
heparin in this group of patients are limited due to either
underrepresentation or even exclusion from trials of these
drugs, leading to uncertainty whether the dose should be
increased with weight proportionally or kept at a maximal
dose (15). Underdosing of anticoagulants could be associated
with increased mortality in this subgroup. However, it is
notable that in our study, there were 4.4 bleeding complica-
tions per mortality in the EO patients versus 3.9 in those
with NW.on of Extreme Obesity Versus Normal BMI With
rdial infarction (STEMI), age, body mass index (BMI), cerebrovascular disease (CVD),
ry intervention (PCI), diabetes mellitus (DM), ejection fraction (EF), chronic kidney
A) class within 2 weeks, cardiac arrest within 24 h, hemoglobin, sex, pre-procedure
tics prior to PCI for STEMI, at least one previously treated lesion within 1 month with
lesion segment category, race, arterial access, site location, proﬁt type, teaching
MI, age, BMI, CVD, PVD, CLD, prior PCI, DM, glomerular ﬁltration rate, renal failure, EF,
within 24 h, at least one previously treated lesion within 1 month with in-stent
or 1), chronic total occlusion, race, arterial access, site location, proﬁt type, teaching
ts with normal BMI. LCL = 95% lower limit; OR ¼ odds ratio; UCL = 95% upper limit.
Table 4
Unadjusted and Multivariate-Adjusted ORs of the Association of Extreme Obesity Versus Normal Weight With Bleeding
and In-Hospital Mortality Stratiﬁed by Presentation With STEMI and Non-STEMI
Outcome Total N
Unadjusted Adjusted
OR 95% CI p Value OR 95% CI p Value
STEMI
Mortality 51,201 0.84 0.76–0.92 <0.001 1.22 1.08–1.39 0.002
Bleeding 51,201 0.77 0.72–0.81 <0.001 0.77 0.71–0.83 <0.001
Non-STEMI
Mortality 250,276 0.66 0.59–0.74 <0.001 1.06 0.93–1.21 0.403
Bleeding 250,276 0.73 0.70–0.77 <0.001 0.82 0.78–0.86 <0.001
OR ¼ odds ratio; other abbreviation as in Table 2.
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ence of sleep apnea or occurrence of in-hospital complications
unrelated to PCI (e.g., aspiration pneumonia, pulmonary
embolism), were not included in the registry and hence not
accounted for in this study. Moreover, the registry does not
include data from all U.S. hospitals that perform PCI, which
introduces the possibility of selection bias.
Conclusions
EO patients who underwent PCI were younger and had less
bleeding compared with NW patients. Despite these dif-
ferences and regardless of access route, in the subgroup of
patients presenting with STEMI, EO was independently
associated with higher in-hospital mortality.
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